Inside the 2015 ASCO Genitourinary Cancers Symposium

Matteo Santoni, Francesco Massari, Roberto Iacovelli, Chiara Ciccarese, Elena Verri, Luciano Burattini, Rodolfo Montironi, Franco Nolè, Giampaolo Tortora, Stefano Cascinu

Research output: Contribution to journalArticlepeer-review

Abstract

The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Rosen Shingle Creek, Orlando, FL, USA, 26-28 February 2015 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium was held in Orlando (FL, USA), from 26 to 28 February 2015. This meeting was focused on 'Integrating Biology into patient-centric care' and represented an attractive opportunity for oncology professionals with a special interest in the diagnosis and treatment of genitourinary tumors. The identification and validation of biomarkers for tumor response had been the focus of several researchers at the symposium, together with the development of novel targeted agents. This report is a summary of the highlights on kidney and prostate tumors presented at the 2015 ASCO Genitourinary Cancers Symposium by various investigators.

Original languageEnglish
Pages (from-to)1859-1862
Number of pages4
JournalFuture Oncology
Volume11
Issue number13
DOIs
Publication statusPublished - Jul 1 2015

Keywords

  • biomarkers
  • prostate cancer
  • renal cell carcinoma
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Inside the 2015 ASCO Genitourinary Cancers Symposium'. Together they form a unique fingerprint.

Cite this